|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61P 25/00 | (2006.01) |
| C07D 207/27 | (2006.01) | ||
| A61K 31/4015 | (2006.01) | ||
| A61P 25/02 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Patento numeris | 3890833 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19813837.2 |
| Europos patento paraiškos padavimo data | 2019-12-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-10-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2019/083594 |
| Data | 2019-12-04 |
| (87) | Numeris | WO 2020/115093 |
| Data | 2020-06-11 |
| (30) | Numeris | Data | Šalis |
| 18210106 | 2018-12-04 | EP |
| (72) |
FARINA, Carlo , IT
SCHERZ, Michael , CH
GHELARDINI, Carla , IT
DI CESARE MANNELLI, Lorenzo , IT
|
| (73) |
Metys Pharmaceuticals AG ,
Gerbergasse 30, 4001 Basel,
CH
|
| (54) | SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE IN A NON-RACEMIC RATIO |
| SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE IN A NON-RACEMIC RATIO |